Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (atsiveria naujas langas)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Šaltinis‎: Pediatr Transplant 2017;21(6):e13017.

Kodas‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (atsiveria naujas langas)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (atsiveria naujas langas)

Bhatia M, Davenport V, Cairo MS.

Šaltinis‎: Leuk Lymphoma 2007;48(1):9-15.

Kodas‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (atsiveria naujas langas)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (atsiveria naujas langas)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Šaltinis‎: Lancet 2003;361(9354):275-80.

Kodas‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (atsiveria naujas langas)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (atsiveria naujas langas)

Fassel H, Bussel JB, Roberts SS, Modak S

Šaltinis‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Kodas‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (atsiveria naujas langas)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (atsiveria naujas langas)

Jacobson AE, Shah N, Setty BA

Šaltinis‎: Pediatr Blood Cancer 2017;64(8):e26473.

Kodas‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (atsiveria naujas langas)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (atsiveria naujas langas)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Šaltinis‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Kodas‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (atsiveria naujas langas)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (atsiveria naujas langas)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Šaltinis‎: Int J Hematol 2015;102(5):626-32.

Kodas‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (atsiveria naujas langas)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (atsiveria naujas langas)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Šaltinis‎: J Pediatr 1996;129(5):656-60.

Kodas‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (atsiveria naujas langas)

Chemotherapy induced thrombocytopenia in pediatric oncology. (atsiveria naujas langas)

Tamamyan G, Danielyan S, Lambert MP

Šaltinis‎: Crit Rev Oncol Hematol 2016;99:299-307.

Kodas‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (atsiveria naujas langas)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (atsiveria naujas langas)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Šaltinis‎: Onkologie 2004;27(2):131-7.

Kodas‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (atsiveria naujas langas)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (atsiveria naujas langas)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Šaltinis‎: Ann Oncol 2005;16(1):139-45.

Kodas‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (atsiveria naujas langas)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (atsiveria naujas langas)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Šaltinis‎: Blood 1998;91(10):3601-6.

Kodas‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (atsiveria naujas langas)